Pyrinodemin A, a cytotoxic *bis*-pyridine alkaloid with a unique *cis*-cyclopent\[*c*\]isoxazolidine moiety, has been isolated from a marine sponge *Amphimedon* sp., and its relative stereostructure was proposed as **1** (Δ^16',17'^) on the basis of spectral data \[[@B1-molecules-10-00312]\]. The unique structure of pyrinodemin A has prompted synthetic chemists to its total synthesis of **1** as well as syntheses of the double bond isomers **2** (Δ^15',16'^) and **3** (Δ^14',15'^) \[[@B2-molecules-10-00312],[@B3-molecules-10-00312],[@B4-molecules-10-00312]\] followed by different proposals of the structural revision of pyrinodemin A to be **2** \[[@B2-molecules-10-00312]\] or **3** \[[@B3-molecules-10-00312],[@B4-molecules-10-00312]\].

In order to examine the correct structure of pyrinodemin A, we have synthesized (+)-**2** and (+)-**3**, the double bond isomers of **1**, as an optically active form, and compared HPLC profiles of the synthetic compounds and pyrinodemin A. In addition, oxidative degradation experiments were performed for a remaining small amount of pyrinodemin A to determine the position of a double bond. In this paper, we describe asymmetric synthesis of (+)-**2** and (+)-**3**, and indication of the structure of pyrinodemin A to be (±)-**2**.

The Δ^15',16'^ double bond isomer (+)-**2** was synthesized as follows ([Scheme 1](#molecules-10-00312-f002){ref-type="scheme"}). The synthesis of hydroxylamine **6a** commenced with known pivaloate **5a** \[[@B5-molecules-10-00312]\]. Oxidation of alcohol **5a** with 2-iodobenzoic acid (IBX) \[[@B6-molecules-10-00312]\] in DMSO and THF afforded its aldehyde. Treatment of the aldehyde with NH~2~OH·HCl and NaOAc in MeOH provided oxime which was reduced with NaBH~3~CN in MeOH to afford hydroxylamine **6a** \[[@B7-molecules-10-00312],[@B8-molecules-10-00312]\]. Condensation of **6a** and optically active aldehyde **7** \[[@B8-molecules-10-00312]\] in CHCl~3~ containing Na~2~SO~4~ at r.t. gave the nitrone **8a**, which was followed by heating to afford *cis*-cyclopent\[*c*\]isoxazolidine \[[@B9-molecules-10-00312]\] **9a** in 58% yield.
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*Reagents and conditions*: (a) IBX, DMSO, THF (69%); (b) H~2~NOH·HCl, AcONa, MeOH (96%); (c) NaBH~3~CN, MeOH, pH 3, 0 °C; (d) Na~2~SO~4~, **6**, CHCl~3~, r.t.\~reflux (58% for 2 steps); (e) 3N HCl, dioxane (80%); (f) NaIO~4~, MeCN, H~2~O, 0 °C; (g) Br-\[Ph~3~^+^(CH~2~)~5~CH~2~OH\], *n*-BuLi, THF, 0 °C (51% for 2 steps); (h) TIPSCl, imidazole, CH~2~Cl~2~ (75%); (i) H~2~, Pd-C, MeOH (93%); (j) DIBAL, CH~2~Cl~2~, -78 °C (75%); (k) IBX, DMSO (80%); (l) Br-\[Ph~3~P^+^(CH~2~)~7~CH~2~OH\], *n*-BuLi, THF, 0 °C (81%); (m) 46% HF, MeCN (55%); (n) CBr~4~, Ph~3~P (80%); (o) 3-methylpyridine, LDA, DMPU, -40 °C (64%)

Treatment of **9a** with 3N HCl in dioxane gave diol, which was converted into its aldehyde by treatment with NaIO~4~ and then into alcohol **10a** by Wittig reaction \[[@B10-molecules-10-00312]\]. Protection of alcohol **10a** as its TIPS ether followed by reduction with Pd-C gave its saturated TIPS ether, which was converted into alcohol **11a** with DIBAL. IBX oxidation of **11a** followed by Wittig reaction \[[@B10-molecules-10-00312]\] afforded its unsaturated alcohol, which was subjected to deprotection with HF to give diol **12a** in 55 %. Treatment of diol **12a** with CBr~4~ and PPh~3~ provided its dibromide, which was coupled with 3-methypyridine using LDA and DMPU \[[@B11-molecules-10-00312]\] in THF to furnish optically active compound (+)-**2**. This is the first synthesis of optical active form of **2**, although its racemic form ((±)-**2**) has been synthesized \[[@B2-molecules-10-00312],[@B3-molecules-10-00312],[@B4-molecules-10-00312]\]. The Δ^14',15'^ double bond isomer (+)-**3** was prepared from pivaloate **5b** by almost same procedure as described for synthesis of (+)-**2** ([Scheme 1](#molecules-10-00312-f002){ref-type="scheme"}).

The position of a double bond and the stereochemistry of pyrinodemin A were examined as follows. Compounds (±)-**1** \[[@B2-molecules-10-00312]\], (±)-**2** \[[@B2-molecules-10-00312]\], and (+)-**3** were subjected to C~18~ HPLC \[Wako sil-II 5C18 RS, Wako Ind., Ltd., 4.6 x 250 mm; flow rate 1.0 mL/min: eluent; MeOH/H~2~O (91:9); UV detection at 263 nm\] and found to be separated (**1**, t~*R*~ 21.6 mim; **2**, t~*R*~ 17.0 min; **3**, t~*R*~ 15.8 min), while the retention time (t~*R*~ 17.0 min) of pyrinodemin A was identical with that of **2** under the same condition, indicating that the position of a double bond of pyrinodemin A corresponded to that (Δ^15',16'^) of **2**. To elucidate the stereochemistry of pyrinodemin A, compound (±)-**2** was subjected to chiral HPLC \[CHIRALCELL OD-H, Daicel Co., Ltd., 4.6 x 250 mm; flow rate 1.0 mL/min: eluent: hexanes/*i*-PrOH (95:5); UV detection at 263 nm\] and found to be separated (t~*R*~ 44 and 47 min), while the retention time of (+)-**2** was 47 min ([Figure 1](#molecules-10-00312-f001){ref-type="fig"}). On the other hand, pyrinodemin A gave the two peaks corresponding to those of (±)-**2** in a ratio of 1:1 under the same conditions, indicating that pyrinodemin A is a 1:1 racemic mixture of **2**. Furthermore, pyrinodemin A was treated with OsO~4~ and then NaIO~4~ to give degradation products, one of which showed an ESIMS fragment ion peak at *m/z* 242 (M+Na)+, corresponding to an aldehyde (**13**) of C-7'\~C-15' segment connected to a pyridine ring ([Scheme 2](#molecules-10-00312-f003){ref-type="scheme"}). From the results described above, it was indicated that the olefin position of pyrinodemin A was C-15' and C-16' (**2**), as proposed by Snider's group \[[@B2-molecules-10-00312]\], and that pyrinodemin A was a 1:1 racemic mixture of **2**.
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Experimental
============

General
-------

Optical rotations were determined on a JASCO P-1030 polarimeter. Infrared spectra were obtained on a JASCO FT/IR-230 spectrometer. Proton and carbon NMR spectra were recorded on a Bruker 600 MHz spectrometer. Chemical shifts are reported in δ values relative to chloroform (δ 7.26 for proton and δ 77.0 for carbon NMR. EI mass spectra were measured on a JEOL JMS-DX303 spectrometer.

*Synthetic Compound* **(+)-2**: \[α\]^25^~D~ +5.5°(*c* 0.6, CHCl~3~); IR (neat) 1575 cm^-1^; ^1^H-NMR (600 MHz, CDCl~3~) δ 1.25\~1.50 (26H, m), 1.50\~1.74 (9H, m), 1.75 (1H, m), 2.01 (4H, m), 2.60 (5H, m), 2.91 (2H, m), 3.50 (1H, m), 4.15 (1H, m), 5.33 (2H, m), 7.22 (2H, m), 7.51 (2H, m), 8.44 (4H, m); ^13^C-NMR (150 MHz, CDCl~3~) δ 26.3, 26.4, 27.0, 27.1, 27.2, 27.5, 27.8, 29.1, 29.3, 29.4, 29.7, 31.1, 33.0, 34.2, 49.9, 57.1, 72.6, 77.7, 123.2, 129.6, 130.0, 135.7, 137.9, 147.1, 149.9; HREIMS *m/z* 573.4643 \[M^+^; calcd for C~38~H~59~N~3~O~1~ 573.4658\].

*Synthetic Compound* **(+)-3**: \[α\]^25^~D~ +6.2°(*c* 0.8, CHCl~3~); IR (neat) 1575 cm^-1^; ^1^H-NMR (600 MHz, CDCl3) δ 1.25\~1.50 (26H, m), 1.50\~1.74 (9H, m), 1.77 (1H, m), 2.00 (4H, m), 2.58 (5H, m), 2.82 (2H, m), 3.45 (1H, m), 4.04 (1H, m), 5.33 (2H, m), 7.18 (2H, m), 7.47 (2H, m), 8.43 (4H, m); ^13^C-NMR (150 MHz, CDCl~3~) δ 26.3, 26.4, 27.1, 28.0, 28.8, 29.1, 31.1, 33.0, 34.3, 49.9, 57.3, 77.7, 123.2, 129.8, 135.7, 137.9, 147.1, 149.9; HREIMS *m/z* 573.4661 \[M+; calcd for C~38~H~59~N~3~O~1~ 573.4658\].
